J

Jade Biosciences Inc
D

JBIO

14.580
USD
-0.34
(-2.28%)
مغلق
آخر تحديث: · متأخرة 15 دقيقة
حجم التداول
19,828
الربح لكل سهم
-2
العائد الربحي
-
P/E
-14
حجم السوق
927,249,902
أصول ذات صلة

العنوان: Jade Biosciences Inc

القطاع: الرعاية الصحية
الصناعة: Biotechnology
Jade Biosciences Inc is a clinical-stage biotechnology company focused on developing therapies for autoimmune diseases. Its flagship candidate, JADE101, targets the cytokine APRIL and is in a Phase 1 clinical trial for the treatment of immunoglobulin A nephropathy. The company's pipeline also includes JADE201, an afucosylated anti-BAFF-R monoclonal antibody, and JADE301, an antibody candidate in preclinical development.